Average Co-Inventor Count = 6.77
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Frosst Canada & Co. (6 from 76 patents)
2. Axys Pharmaceuticals, Inc. (4 from 40 patents)
3. Kaneq Pharma Inc. (4 from 4 patents)
4. Merck + Co., Inc. (3 from 4,770 patents)
5. Merck Canada Inc. (2 from 40 patents)
6. Other (1 from 832,680 patents)
7. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
8. Merk Frosst Canada & Co. (1 from 1 patent)
9. Merck Frosst Canada, Inc. (212 patents)
18 patents:
1. 9334295 - Fused aromatic PTP-1B inhibitors
2. 8927526 - Fused aromatic PTP-1B inhibitors
3. 8481742 - Fused aromatic PTP-1B inhibitors
4. 8318748 - Cathepsin cysteine protease inhibitors
5. 8168815 - Fused aromatic PTP-1B inhibitors
6. 8063105 - Renin inhibitors
7. 7973037 - Cathepsin cysteine protease inhibitors
8. 7405229 - Cathepsin cysteine protease inhibitors
9. 7375134 - Cathepsin cysteine protease inhibitors
10. 7012075 - Cathepsin cysteine protease inhibitors
11. 6699856 - Pyrazinones, compositions containing such compounds and methods of use
12. 6552168 - Gamma-ketoacid tetrapeptides as inhibitors of caspase-3
13. 6498151 - Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors
14. 6486141 - Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
15. 6465444 - Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors